CD8A and sarcoma: Unlike previous studies that reported DAC-induced increases in CD8+ T cells, we found no change in levels of cytotoxic T cells from sarcomas treated with PBS, Gem, or DAC (32.03%, 30.87%, and 28.26%, respectively).